Molecular Therapy — Nucleic Acids · 2019 · 61 citations · 38 references
Life SciencesGeneticsNeurologyMolecular NeurobiologyMolecular NeuroscienceNeurodegenerationHuntington DiseaseMolecular Basis Of NeurodegenerationMolecular NeurogeneticsNeurodegenerative DiseasesNeurodegenerative DisordersSpinocerebellar AtaxiasHuntington's Disease ModelsPolyglutamine DiseasesRepeat Expansion MutationsSpinocerebellar Ataxia ModelsSpinocerebellar Ataxia Type 3Spinocerebellar Ataxia Type 7Toxic Protein ExpressionTransgenic Mouse Models
mice. These findings support the therapeutic potential of a single CAG repeat-targeting AON for the treatment of multiple polyglutamine disorders.
38
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
Richard S. Finkel, Eugenio Mercuri, Basil T. Darras et al. · New England Journal of Medicine · 2017 · 2.3K citations · Full text
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
Eugenio Mercuri, Basil T. Darras, Claudia A. Chiriboga et al. · New England Journal of Medicine · 2018 · 1.4K citations · Full text
Medicine, Neurology, Neuroscience +17
Ataxin-1 Nuclear Localization and Aggregation
Ivan A. Klement, Pamela J. Skinner, Michael D. Kaytor et al. · Cell · 1998 · 962 citations · Full text
Antisense oligonucleotides: basic concepts and mechanisms.
Nathalie Dias, C.A. Stein · PubMed · 2002 · 750 citations